Clarification on availability of benefit under Focus Product Scheme on the export of item 'OMEPRAZOLE AND LANSOPRAZOLE'.

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... /2015 TO ALL IEC HOLDERS ALL EPCs ALL CHAMBERS OF TRADE AND INDUSTRY FEDERATION OF INDIAN EXPORT ORGANISATIONS M/s J.B. Chemicals Pharmaceuticals Ltd. New Delhi ALL RA's OF DGFT Subject: Clarification on availability of benefit under Focus Product Scheme on the export of item 'OMEPRAZOLE AND LANSOPRAZOLE'. The product description appearing under ITC .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... ulk drugs under any brand name in the market. 3. Department of Pharmaceuticals have been consulted who have clarified that this entry be interpreted as two specific entries containing finished dosage forms based upon either Omeprazole or Lansoprazole used as the Active Pharmaceuticals Ingredients rather than treating this entry as a formulated product containing both of these bulk drugs. .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X